Time to Functional Outcome Optimization After Musculoskeletal Tumor Resection

Abstract

BackgroundThere is ample literature describing surgical outcomes after oncologic musculoskeletal tumor surgery, however, there is limited understanding of the time to optimization of functional outcome scores after resection. The purpose of this study was to identify the time to functional outcome optimization of Musculoskeletal Tumor Society (MSTS) scores after surgery for bone and soft tissue tumors and to identify factors correlated with recovery. MethodsWe retrospectively reviewed 187 patients from April 2016 to May 2021 that had undergone surgical treatment for musculoskeletal tumors. We assessed MSTS scores to determine the time to optimization and evaluated patient-specific and surgical factors for any influence on post-operative recovery. ResultsThe majority of patients (92%) achieved their optimized score in one year or less. Eighty-two percent achieved the maximum MSTS score of 30. Osseous tumors, malignancy, adjuvant treatment with radiation and/or chemotherapy, deep location for soft tissue tumors, and bony work required for soft tissue tumors all significantly impacted time to MSTS score optimization. ConclusionThe majority of patients with musculoskeletal tumors undergoing surgery can be expected to improve up to one year postoperatively. Those with bone tumors, malignant tumors, treatment with radiation and/or chemotherapy, deep soft tissue tumors, and bony work for soft tissue tumors can expect to have a longer recovery time and are at higher risk for not achieving premorbid functionality.

Cross-Cultural Adaptation and Validation of the Romanian Musculoskeletal Tumor Society Scoring System for Patients with Extremity Bone Sarcomas

“…The mean MSTS Score was 23.91 for the retests. Patients with upper limb sarcoma had an average of 23.1 (range, 20-29) on retests (Table 6), while patients with lower limb sarcoma had an average of 24.1 (range, [19][20][21][22][23][24][25][26][27][28][29].…”

“…Each complication with consequent additional surgeries may result in a lower functional outcome. In the follow-up, the most important factor that influences the MSTS score is the occurrence of complications and these can cause changes in both the patient's subjective indices and the objective indices [13,[27][28][29].…”

“…The literature concerning clinical and mechanical outcomes in bone sarcoma healthcare is characterized by outcome measures of function. Moreover, over the past decades, there has been an increasing amount of literature reporting an improvement in the quality of life outcomes in these patients [11,12,[27][28][29][30]. This way, the MSTS score has played an important role in the follow-up process of patients who underwent limb-salvage surgery for bone sarcomas [31][32][33][34][35].…”

Effects of an Exercise Intervention on Gait Function in Young Survivors of Osteosarcoma with Megaendoprosthesis of the Lower Extremity—Results from the Pilot Randomized Controlled Trial proGAIT

“…By that time, rehabilitation no longer needs to be site-specific, and varying site-specific early functional impairments had usually recovered. In addition, no spontaneous improvement without training was expected after 12 months [ 21 ].…”